This is a service of EIN News a digital news provider
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
United States Drugs & Pharmaceutical Industry News is an EIN News Service for health professionals. Constantly updated news and information about United States Health.
FORMATS: RSS | EMAIL

Latest United States Drugs & Pharmaceutical Industry News

Sort by: relevance (24 hours) relevance date
  • Prospect of More U.S. Troops Worries Wary Afghan Public 7 Nov 2009 01:30 GMT
    ... at Kabul University protested last month against American forces, set off by a rumor that ... they have come to believe that the United States must want the fighting to go on. ... “Those countries that are working with the U.S. and are friends of theirs are Saudi ...

  • Prospect of More U.S. Troops Worries Afghan Public 7 Nov 2009 02:11 GMT
    ... at Kabul University protested last month against American forces, set off by a rumor that ... they have come to believe that the United States must want the fighting to go on. ... “Those countries that are working with the U.S. and are friends of theirs are Saudi ...

  • FDA Approves Gloucester Pharmaceuticals' Istodax for Patients with Cutaneous T-cell Lymphoma 7 Nov 2009 00:53 GMT
    ... - Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved (romidepsin) ... Colorado Cancer Center and past-President of the American Society of Clinical Oncology said, "Istodax offers ... CTCL were accessed for efficacy in the United States, Europe and Australia. Study 1, sponsored by ...

  • FDA Approves Gloucester Pharmaceuticals' ISTODAX(R) For Patients With Cutaneous T-cell Lymphoma 7 Nov 2009 00:51 GMT
    ... Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® ... Colorado Cancer Center and past-President of the American Society of Clinical Oncology said, "ISTODAX offers ... CTCL were accessed for efficacy in the United States, Europe and Australia. Study 1, sponsored by ...

  • Report on the US pharmaceuticals and healthcare markets 7 Nov 2009 06:37 GMT
    ... ) has announced the addition of the "United States Pharmaceuticals and Healthcare Report Q4 2009" report to ... also provide a major downside for patented drugs. The shape of economic recovery in the ...

  • Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 7 Nov 2009 15:16 GMT
    ... Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused ... 12, 2009 Time: 5:00 p.m. EST Dial-in (U.S.): 877-874-1589 Dial-in (International): 719-325-4805 A simultaneous webcast ... development and commercialization of Intermezzo® in the United States. For further information, please visit the company's ...

  • U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat 7 Nov 2009 01:57 GMT
    ... U.S. and European Experts Applaud Creation of New ... on Global Antibiotic Resistance Threat From the PharmaLive.com News Archive - Nov. 06, 2009 Nov. ... that seeks cooperative ways in which the United States and EU countries can help combat the ...

  • News and FDA Updates for CVS (NYSE:CVS), NovaDel Pharma (NYSE:NVD), NexMed (Nasdaq:NEXM) 7 Nov 2009 08:30 GMT
    ... and FDA Updates for CVS (NYSE:CVS), NovaDel Pharma (NYSE:NVD), NexMed (Nasdaq:NEXM) Pasadena, CA - 11/06/09 ... received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled "Buccal, Polar ...

  • BLOG: The Platform: Costly new drugs: A crisis for one family, a quandry for U.S. [St. Louis Post-Dispatch] 7 Nov 2009 18:37 GMT
    ... BLOG: The Platform: Costly new drugs: A crisis for one family, a quandry ... had $2.7 billion in sales in the United States last year and more than $3.5 billion ... extend life at all. In March, Swiss pharmaceutical giant Roche agreed to buy Genentech for ...

  • The Lowe Law Firm Files Suit over Alleged Botox Overdose 7 Nov 2009 02:13 GMT
    ... Suit over Alleged Botox Overdose From the PharmaLive.com News Archive - Nov. 06, 2009 Patient ... paralysis after the drug was administered ST. LOUIS--(BUSINESS WIRE)--Nov 6, 2009 - St. Louis-based The ... product liability and commercial cases throughout the United States. Contact: The Lowe Law Firm Jeff Lowe, ...

  • WEEKAHEAD-The view from Reuters editors in the Americas 7 Nov 2009 02:50 GMT
    ... starting Nov. 8. -- HEALTHCARE REFORM - U.S. House legislation heads for passage -- OBAMA ... version of a massive overhaul of the American healthcare system in the coming days. We'll ... new president takes office in January. The United States had brokered the deal but now appears ...

  • NeurogesX Reports Third Quarter 2009 Results 7 Nov 2009 04:30 GMT
    ... of Qutenza(TM) E.U. Marketing Authorization to Astellas Pharma Europe Ltd. Made significant progress in commercial ... three key initiatives: 1) supporting the ongoing U.S. Food and Drug Administration (FDA) review of ... potential commercial launch of Qutenza in the United States pending FDA approval and 3) supporting Astellas ...

  • Are doctors the problem? 7 Nov 2009 04:30 GMT
    ... York ( ) - Nowhere in the United States has more doctors at its beck and ... diabetes treatment specialist. Two decades worth of U.S. healthcare data analyzed by Dartmouth Medical School ... from major health industry associations like the American Medical Association and the pharmaceutical industry has ...

  • Istodax Approved for Cutaneous T-Cell Lymphoma 7 Nov 2009 14:31 GMT
    ... Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals drug Istodax (romidepsin) has been approved by ... Istodax (romidepsin) has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell ... the lymph nodes, blood and viscera, the drug maker said. Blood parameters should be carefully monitored ...

  • Istodax Approved for Cutaneous T-Cell Lymphoma 7 Nov 2009 14:54 GMT
    ... Nov. 6 (HealthDay News) -- The Gloucester Pharmaceuticals drug Istodax (romidepsin) has been approved by ... Istodax (romidepsin) has been approved by the U.S. Food and Drug Administration to treat cutaneous T-cell ... the lymph nodes, blood and viscera, the drug maker said. Blood parameters should be carefully monitored ...


1 - 15 / 13712      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS UNITED STATES DRUGS & PHARMACEUTICAL INDUSTRY NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.